TPA, a well-known oxidant tumor promoter [47] induces translocation of PKCδ from the cytoplasm to mitochondria and this translocation results in the release of cytochrome c and the activation of caspase-3 [48]. This evidence concerns the gene PRKCD and neoplasm.